High ionized calcium levels were associated with an increased risk for hyperparathyroidism, especially among men.

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

There’s no cure for hypoparathyroidism, but treatment options like calcium supplements, diuretics, and parathyroid hormone therapy can help regulate your calcium and phosphate levels.

Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical ...

LONDON, UK I March 17, 2025 I High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary ...

manifested by intact parathyroid hormone levels below normal. We aimed to evaluate intact parathyroid hormone levels both during normocalcemia and at hypocalcemia, in this population. Study Design ...

A phase 3 trial of AstraZeneca’s $800 million rare disease candidate has met its primary endpoint. The update keeps ...

Pariacalcitol is a type of vitamin D and is believed to be a positive way to manage CKD complications.

People with unexpected osteoporosis should be considered for celiac disease testing. Celiac disease is a condition of damage ...